Marcellene H Franzen1,2, Michelle M LeRiger1,2, Kaitlyn P Pellegrino1,2, Jane A Kugler1,2, William B Rizzo3. 1. Department of Anesthesiology, University of Nebraska Medical Center, Omaha, NE, USA. 2. Division of Pediatric Anesthesiology, Children's Hospital and Medical Center, Omaha, NE, USA. 3. Department of Pediatrics and Child Health Research Institute, University of Nebraska Medical Center, Omaha, NE, USA.
Abstract
BACKGROUND: Sjögren-Larsson syndrome is a rare inherited neurocutaneous disorder characterized by congenital ichthyosis, spasticity, intellectual disability, seizures, and ophthalmologic changes. Most individuals with Sjögren-Larsson syndrome live well into adulthood and often require surgical intervention to manage their symptomatology. AIMS: The aim of this work was to review the clinical aspects of Sjögren-Larsson syndrome, highlight the unique anesthetic considerations associated with this disease, and provide practical recommendations about anesthetic management. METHODS: A retrospective case review from February 2013 to October 2019 was performed based on subject participation in a Sjögren-Larsson syndrome longitudinal study at the University of Nebraska Medical Center. Anesthetic and surgical records were reviewed for the following data: age, sex, relevant comorbid conditions, anesthetic induction and maintenance agents, intravenous and oral analgesics, muscle relaxants, and anesthetic-related complications. RESULTS: Fourteen patients with Sjögren-Larsson syndrome undergoing 48 anesthetic events were identified. A variety of anesthetic techniques was utilized. No serious adverse events were encountered. The most common clinical observations were related to the ichthyosis seen in Sjögren-Larsson syndrome, which led to difficulty in adherence of electrocardiogram leads and intravenous catheter dressings. CONCLUSIONS: We found that anesthesia can be safely administered in patients with Sjögren-Larsson syndrome. Providers should be aware of anesthetic management issues in Sjögren-Larsson syndrome including challenges placing and securing lines and monitors secondary to the ichthyosis.
BACKGROUND: Sjögren-Larsson syndrome is a rare inherited neurocutaneous disorder characterized by congenital ichthyosis, spasticity, intellectual disability, seizures, and ophthalmologic changes. Most individuals with Sjögren-Larsson syndrome live well into adulthood and often require surgical intervention to manage their symptomatology. AIMS: The aim of this work was to review the clinical aspects of Sjögren-Larsson syndrome, highlight the unique anesthetic considerations associated with this disease, and provide practical recommendations about anesthetic management. METHODS: A retrospective case review from February 2013 to October 2019 was performed based on subject participation in a Sjögren-Larsson syndrome longitudinal study at the University of Nebraska Medical Center. Anesthetic and surgical records were reviewed for the following data: age, sex, relevant comorbid conditions, anesthetic induction and maintenance agents, intravenous and oral analgesics, muscle relaxants, and anesthetic-related complications. RESULTS: Fourteen patients with Sjögren-Larsson syndrome undergoing 48 anesthetic events were identified. A variety of anesthetic techniques was utilized. No serious adverse events were encountered. The most common clinical observations were related to the ichthyosis seen in Sjögren-Larsson syndrome, which led to difficulty in adherence of electrocardiogram leads and intravenous catheter dressings. CONCLUSIONS: We found that anesthesia can be safely administered in patients with Sjögren-Larsson syndrome. Providers should be aware of anesthetic management issues in Sjögren-Larsson syndrome including challenges placing and securing lines and monitors secondary to the ichthyosis.
Authors: Michèl A A P Willemsen; Marinette Van Der Graaf; Marjo S Van Der Knaap; Arend Heerschap; Peter H M F Van Domburg; Fons J M Gabreëls; Jan J Rotteveel Journal: AJNR Am J Neuroradiol Date: 2004-04 Impact factor: 3.825
Authors: Joris Fuijkschot; Thomas Theelen; Marieke M B Seyger; Marinette van der Graaf; Imelda J M de Groot; Ron A Wevers; Ronald J A Wanders; Hans R Waterham; Michèl A A P Willemsen Journal: J Inherit Metab Dis Date: 2012-07-26 Impact factor: 4.982
Authors: Judith Verhoog; Joris Fuijkschot; Michèl Willemsen; Marjolijn Ketelaar; Jan Rotteveel; Jan Willem Gorter Journal: Dev Med Child Neurol Date: 2008-01 Impact factor: 5.449
Authors: Joris Fuijkschot; Ben Maassen; Jan Willem Gorter; Marjo van Gerven; Michèl Willemsen Journal: Dev Neurorehabil Date: 2009-04 Impact factor: 2.308
Authors: William B Rizzo; Dana S'Aulis; M Anitia Jennings; Debra A Crumrine; Mary L Williams; Peter M Elias Journal: Arch Dermatol Res Date: 2010-01-05 Impact factor: 3.017
Authors: Pippa Staps; Judith van Gaalen; Peter van Domburg; Peter M Steijlen; Sacha Ferdinandusse; Tom den Heijer; Marieke M B Seyger; Thomas Theelen; Michèl A A P Willemsen Journal: JIMD Rep Date: 2020-03-25